Drug Digest: Emerging Therapies in All Shapes and Sizes

In this episode of Drug Digest, Pharmaceutical Technology editors, Felicity Thomas and Feliza Mirasol, examine the topic of emerging therapies in more detail, covering subjects such as the challenges of scale, the potential benefits of drug delivery innovation, importance of early analytical studies, the evolution of the regulatory landscape, and differences between regional regulatory requirements.

Interviews featuring

Steven Lynn, Executive Vice President, Pharmaceuticals, Regulatory Compliance Associates (RCA), has 24 years of quality and regulatory compliance related experience, is an expert in Current Good Manufacturing Practices compliance related matters and has significant experience with other GxP quality compliance and regulatory issues.

Alexander Natz, Secretary General of the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE), advises innovative pharmaceutical and biotech companies, including start-ups, in regulatory and pricing & reimbursement matters from the EU law and German law perspective.

Sponsors

This episode of Drug Digest is sponsored by:

• Adare
• Aizon
• BIOVECTRA
• CoreRX
• PPD
• Veltek

About Drug Digest

Drug Digest is a tech talk video series with the Pharmaceutical Technology editors, who interview experts to discuss the emerging opportunities, obstacles, and advances in the pharmaceutical and biopharmaceutical industry for the research, development, formulation, analysis, upstream and downstream processing, manufacturing, supply chain, and packaging of drug products.

Upcoming episodes

• June 2022: Biopharmaceutical drug development and manufacturing
• August 2022: Aseptic processing and manufacturing
• September 2022: Solid dosage drug development
• November 2022: Automating pharma and biopharma processes